Czechia· CZ-0202821

STOPTUSSIN

A antitussiva und expektoranzien product containing butamirate citrate + guaifenesin, registered in Czechia by TEVA Czech Industries s.r.o., Opava-Komárov. The same ATC class is registered in 6 of our 19 countries.

ATC R05FB02

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedSTOPTUSSINATCR05FB02REGISTER NO.CZ-0202821PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Antitussiva und expektoranzien is registered in 6 of 19 countries.

Countries holding a registration under ATC R05FB02 (antitussiva und expektoranzien), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 5 of them publish a price we can compare per daily dose

Antitussiva und expektoranzien · ATC R05FB02

6 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
BUTAMIRATE CITRATE + GUAIFENESIN
Manufacturer
TEVA Czech Industries s.r.o., Opava-Komárov
Country
Czechia (CZ)
ATC code
R05FB02
ATC class
Antitussiva und Expektoranzien
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under R05FB02

Antitussiva und expektoranzien, as other registers publish it.

All antitussiva und expektoranzien products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Lithuania · Stoptussin
  • Latvia · Stoptussin
  • Slovakia · Stoptussin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f1c98420-48a5-46ec-bd21-a9b27254e2ea
GET /v1/drugs/f1c98420-48a5-46ec-bd21-a9b27254e2ea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "SIR",
  "source": "sukl",
  "strength": "0,8MG/ML+20MG/ML",
  "pack_size": "1X100ML II",
  "substance": "BUTAMIRATE CITRATE + GUAIFENESIN",
  "cz_kod_sukl": "0202821",
  "product_type": "CH",
  "substance_codes": "1985,684",
  "registration_state": "B",
  "registration_number": "36/256/05-C"
}

See everything about antitussiva und expektoranzien.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.